Heller Vivien, Wang Lei, Schneider Edith, Gerstner Mirjam, Bajer Luana, Decker Robin, Boenig Halvard, Lausen Joern
Department of Eukaryotic Genetics, Institute of Biomedical Genetics, University of Stuttgart, Stuttgart, Germany.
Institute for Transfusion Medicine and Immunohematology and German Red Cross Blood Service BaWüHe, Institute Frankfurt, Faculty of Medicine, Goethe University, Frankfurt, Germany.
J Biol Chem. 2025 Feb;301(2):108119. doi: 10.1016/j.jbc.2024.108119. Epub 2024 Dec 22.
Erythropoiesis is controlled by transcription factors that recruit epigenetic cofactors to establish and maintain erythrocyte-specific gene expression patterns while repressing alternative lineage commitment. The transcription factor TAL1 (T-cell acute lymphocytic leukemia 1) is critical for establishing erythroid gene expression. It acts as an activator or repressor of genes, depending on associated epigenetic cofactors. Understanding the epigenetic function of TAL1 during erythropoiesis is key to improving in vitro erythroid differentiation and understanding pathological erythropoiesis. Therefore, the regulatory mechanisms that control the function of TAL1 during erythropoiesis are under intense investigation. Here, we show that TAL1 interacts with protein-arginine-methyltransferase-6 (PRMT6) on the ID3 (inhibitor-of-DNA-binding-3) gene in K562 and hCD34+ cells. The ID protein family is a critical transcriptional regulator of hematopoietic cell differentiation. We show that TAL1 and PRMT6 are present at the ID3 promoter, and that TAL1 is involved in the recruitment of PRMT6. Here, PRMT6 epigenetically regulates ID3 expression by mediating dimethylation of histone 3 at arginine 2. Thus, TAL1-PRMT6 epigenetically represses ID3 expression in progenitors, which is relieved upon erythroid differentiation, leading to increased expression. Overexpression of ID3 in primary hCD34+ cells enhances erythropoiesis. Our results show that a TAL1-PRMT6 complex regulates genes important for erythropoiesis, such as ID3. Manipulation of ID3 expression may be a way to promote in vitro differentiation of hCD34+ cells into erythrocytes.
红细胞生成受转录因子控制,这些转录因子招募表观遗传辅因子以建立和维持红细胞特异性基因表达模式,同时抑制其他谱系分化。转录因子TAL1(T细胞急性淋巴细胞白血病1)对于建立红系基因表达至关重要。它根据相关的表观遗传辅因子作为基因的激活剂或抑制剂。了解TAL1在红细胞生成过程中的表观遗传功能是改善体外红系分化和理解病理性红细胞生成的关键。因此,在红细胞生成过程中控制TAL1功能的调控机制正在深入研究中。在这里,我们表明TAL1在K562和hCD34 +细胞中的ID3(DNA结合抑制剂3)基因上与蛋白质精氨酸甲基转移酶6(PRMT6)相互作用。ID蛋白家族是造血细胞分化的关键转录调节因子。我们表明TAL1和PRMT6存在于ID3启动子处,并且TAL1参与PRMT6的募集。在这里,PRMT6通过介导组蛋白3在精氨酸2处的二甲基化在表观遗传上调节ID3表达。因此,TAL1 - PRMT6在祖细胞中表观遗传地抑制ID3表达,在红系分化时这种抑制解除,导致表达增加。在原代hCD34 +细胞中过表达ID3可增强红细胞生成。我们的结果表明,TAL1 - PRMT6复合物调节对红细胞生成重要的基因,如ID3。操纵ID3表达可能是促进hCD34 +细胞体外分化为红细胞的一种方法。